ArticleESMO open2021

Response to comment on "Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indications".

M G Krebs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.